INT113566

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.55
First Reported 2003
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 4
Total Number 4
Disease Relevance 2.70
Pain Relevance 0.67

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

peptidase activity (PLAU) signal transduction (PLAU) extracellular space (PLAU)
extracellular region (PLAU) plasma membrane (PLAU)
Anatomy Link Frequency
PC-3 2
PLAU (Homo sapiens)
Pain Link Frequency Relevance Heat
aspirin 18 99.24 Very High Very High Very High
cINOD 6 94.32 High High
COX-2 inhibitor 6 57.68 Quite High
metalloproteinase 3 5.00 Very Low Very Low Very Low
COX2 1 5.00 Very Low Very Low Very Low
cytokine 1 5.00 Very Low Very Low Very Low
Inflammation 1 5.00 Very Low Very Low Very Low
Osteoarthritis 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cancer 68 99.84 Very High Very High Very High
Prostate Cancer 8 98.72 Very High Very High Very High
Carcinoma 12 97.44 Very High Very High Very High
Pancreatic Cancer 2 97.40 Very High Very High Very High
INFLAMMATION 6 93.56 High High
Adhesions 8 90.40 High High
Knee Osteoarthritis 1 80.68 Quite High
Metastasis 19 79.40 Quite High
Osteoarthritis 1 50.00 Quite Low
Skin Cancer 4 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Here we show that aspirin inhibits NF-kappaB, resulting in the suppression of uPA secretion from the highly invasive human prostate cancer cells PC-3.
Negative_regulation (suppression) of Localization (secretion) of uPA in PC-3 associated with aspirin and prostate cancer
1) Confidence 0.55 Published 2003 Journal Int. J. Oncol. Section Abstract Doc Link 14532966 Disease Relevance 1.06 Pain Relevance 0.35
ELISA showed the inhibitions of u-PA secretion in chondral cultures by diclofenac and rofecoxib as well as in chondral and synovial cultures by nimesulide, celecoxib and etoricoxib at 48 h.
Negative_regulation (inhibitions) of Localization (secretion) of u-PA
2) Confidence 0.55 Published 2008 Journal Clin. Biochem. Section Body Doc Link 17996201 Disease Relevance 0.08 Pain Relevance 0
We have recently demonstrated that constitutively active nuclear factor-kappa B (NF-kappaB) is responsible for the increased secretion of uPA and that inhibition of NF-kappaB suppresses secretion of uPA and cell migration of highly invasive cancer cells.
Negative_regulation (suppresses) of Localization (secretion) of uPA associated with cancer
3) Confidence 0.41 Published 2003 Journal Int. J. Oncol. Section Abstract Doc Link 14532966 Disease Relevance 0.96 Pain Relevance 0.29
COX-2, MMPs, and uPA-system inhibition impacts on neo-angiogenic potential of tumour cells
Negative_regulation (inhibition) of Localization (potential) of uPA associated with cancer
4) Confidence 0.13 Published 2010 Journal BMC Cancer Section Body Doc Link PMC2841144 Disease Relevance 0.60 Pain Relevance 0.03

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox